HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Relationship of complement activation route with clinical manifestations in Japanese patients with systemic lupus erythematosus: a retrospective observational study.

AbstractOBJECTIVES:
To assess the relationship between the complement activation route and clinical manifestations in systemic lupus erythematosus (SLE).
METHODS:
Patients with SLE in whom complement activation occurred were divided into two groups: those in whom the complement system was mainly activated through the classical pathway (low serum C3 and C4 levels; CP group); and those in whom the complement system was solely activated through the alternative pathway (low serum C3 with normal C4 levels; AP group). Clinical manifestations were compared between the groups.
RESULTS:
The CP group had higher frequencies of arthritis, serositis, and nephritis, and a higher prevalence of anti-DNA antibodies compared to the AP group (arthritis: 50.0% vs. 13.0%, p = 0.0014; serositis: 37.5% vs. 13.0%, p = 0.0257; nephritis: 63.6% vs. 21.7%, p = 0.0003; anti-DNA antibodies: 73.9% vs. 30.4%, p = 0.0001). In contrast, the AP group had a higher frequency of anti-phospholipid (anti-PL) antibodies and a higher prevalence of antiphospholipid syndrome (APS) (anti-PL antibodies: 70.6% vs. 37.3%, p = 0.0136; APS: 39.1% vs. 5.7%, p < 0.0001).
CONCLUSIONS:
Our results suggest that a different complement system mechanism may act in the pathogenesis of APS in patients with SLE.
AuthorsHiroshi Watanabe, Mitsuru Sugimoto, Tomoyuki Asano, Shuzo Sato, Eiji Suzuki, Atsushi Takahashi, Kyoko Katakura, Hiroko Kobayashi, Hiromasa Ohira
JournalModern rheumatology (Mod Rheumatol) Vol. 25 Issue 2 Pg. 205-9 (Mar 2015) ISSN: 1439-7609 [Electronic] England
PMID25036235 (Publication Type: Journal Article, Observational Study)
Chemical References
  • Antibodies, Antiphospholipid
  • Complement C3
  • Complement C4
Topics
  • Adolescent
  • Adult
  • Aged
  • Antibodies, Antiphospholipid (blood)
  • Antiphospholipid Syndrome (blood, diagnosis, immunology)
  • Complement Activation (immunology)
  • Complement C3
  • Complement C4
  • Female
  • Humans
  • Lupus Erythematosus, Systemic (blood, diagnosis, immunology)
  • Male
  • Middle Aged
  • Retrospective Studies
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: